Combining multiple approaches for the secondary prevention of vascular events after stroke - A quantitative modeling study

被引:268
作者
Hackam, Daniel G.
Spence, J. David
机构
[1] Univ Toronto, Dept Med, Div Clin Pharmacol & Toxicol, Toronto, ON, Canada
[2] Toronto Rehabil Inst, Cardiac Rehabil & Secondary Prevent Program, Toronto, ON, Canada
[3] Inst Clin Evaluat Sci, Toronto, ON, Canada
[4] Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, London, ON N6A 5C1, Canada
[5] Univ Western Ontario, Div Clin Pharmacol, London, ON, Canada
[6] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada
关键词
cerebrovascular disease; medical Rx; prevention; risk factor modification; secondary prevention; statistical models; stroke; systematic review;
D O I
10.1161/STROKEAHA.106.475525
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - Numerous effective strategies for the secondary prevention of cardiovascular events in high- risk patients have now been established. We sought to calculate the cumulative benefit of combining multiple strategies for preventing recurrent events in patients with a history of ischemic stroke or transient ischemic attack. Methods - A comprehensive literature search was undertaken to identify meta- analyses of randomized controlled trials reporting on the efficacy of secondary prevention strategies. The baseline incidence of vascular events was modeled from the Life Long After Cerebral Ischemia study. Strategies were combined on a multiplicative scale and cumulative risk reductions were computed over a 5- year interval. Results - The combination of 5 proven strategies applied to survivors of an initial stroke or transient ischemic attack - dietary modification, exercise, aspirin, a statin, and an antihypertensive agent - could result in a cumulative relative risk reduction of 80%. Given a 5- year major cardiovascular event rate of 24%, this translates to a number needed to treat of about 5. Further gains would result from applying multimodality therapy over longer intervals and enriching the base strategy with dual antiplatelet therapy, high- dose statins, and more intensive blood pressure - lowering. Even more benefit would be present in high- risk subgroups with the addition, where appropriate, of carotid endarterectomy, moderate intensity oral anticoagulants, glycemic control, and smoking cessation. Conclusions - At least four- fifths of recurrent vascular events in patients with cerebrovascular disease might be prevented by application of a comprehensive, multifactorial approach.
引用
收藏
页码:1881 / 1885
页数:5
相关论文
共 34 条
[1]  
[Anonymous], 1993, LANCET, V342, P1255, DOI DOI 10.1016/0140-6736(93)92358-Z
[2]  
[Anonymous], 2004, COCHRANE DB SYST REV
[3]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[4]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[5]   Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy [J].
Cannon, Christopher P. ;
Steinberg, Benjamin A. ;
Murphy, Sabina A. ;
Mega, Jessica L. ;
Braunwald, Eugene .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (03) :438-445
[6]   Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history - The PROGRESS trial [J].
Chapman, N ;
Huxley, R ;
Anderson, C ;
Bousser, MG ;
Chalmers, J ;
Colman, S ;
Davis, S ;
Donnan, G ;
MacMahon, S ;
Neal, B ;
Warlow, C ;
Woodward, M .
STROKE, 2004, 35 (01) :116-121
[7]   Meta-analysis: Secondary prevention programs for patients with coronary artery disease [J].
Clark, AM ;
Harding, L ;
Vandermeer, B ;
McAlister, FA .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (09) :659-672
[8]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[9]   Mortality risk reduction associated with smoking cessation in patients with coronary heart disease - A systematic review [J].
Critchley, JA ;
Capewell, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (01) :86-97
[10]   Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials [J].
Dagenais, Gilles R. ;
Pogue, Janice ;
Fox, Kim ;
Simoons, Marteen L. ;
Yusuf, Salim .
LANCET, 2006, 368 (9535) :581-588